ALLMedicine™ Multiple Sclerosis Center

Mar 18th, 2023 - Optic neuritis (ON) is one of the most frequently seen neuro-ophthalmic causes of vision loss worldwide. Typical ON is often idiopathic or seen in patients with multiple sclerosis, which is well described in the landmark clinical trial, the Optic ...

Mar 18th, 2023 - Characterize patient-reported signs and symptoms of urinary tract infections (UTI) in patients with neurogenic bladder (NB) to inform development of an intervention to improve the accuracy of UTI diagnosis. Retrospective cohort study, of adults wi...

Mar 18th, 2023 - The heterogeneous symptoms of multiple sclerosis (MS) can considerably impact the lives of people with MS (PwMS). The aim of this study was to describe the extent of restrictions in different life domains that PwMS experience in relation to their ...

Mar 18th, 2023 - Multiple sclerosis (MS) is a debilitating disease that requires prolonged treatment with often severe side effects. One experimental MS therapeutic currently under development is a single amino acid mutant of a plant peptide termed kalata B1, of t...

Mar 17th, 2023 - Theranostic imaging methods could greatly enhance our understanding of the distribution of CNS-acting drugs in individual patients. Fluorine-19 magnetic resonance imaging (19F MRI) offers the opportunity to localize and quantify fluorinated drugs ...

Jun 18th, 2022 - Supporting the Role of Parenting for People With Multiple Sclerosis: A Guide for Clinicians.|2022|Rider JV,Selim J,|

Sep 29th, 2020 - Vision Problems in Multiple Sclerosis.|2020|Costa SL,Pandey K,Hrdina J,Rondon M,Devos H,|

Jul 18th, 2020 - There is an unmet need in multiple sclerosis (MS) therapy for treatments to stop progressive disability. The development of treatments may be accelerated if novel biomarkers are developed to overcome the limitations of traditional imaging outcomes...

May 14th, 2020 - Practical Sleep Information for People With Multiple Sclerosis.|2020|Siengsukon C,Karahan AY,Strober L,|

Jun 5th, 2019 - To establish recommendations on immunization for patients with multiple sclerosis (MS) BACKGROUND: Vaccines have been suspected in the past to trigger MS and relapses. With the extension of the immunoactive treatment arsenal, other concerns have b...

Mar 15th, 2023 - The main purpose of this study is to investigate the safety and tolerability of intermittent Theta Burst (iTBS), its effectiveness in alleviating depressive symptoms, concomitant neuropsychiatric symptoms such as anxiety and fatigue in people with...

Mar 10th, 2023 - Objectives. The primary aim of this pilot study is to assess the effects of short-term, high-dose corticosteroid administration on the 12-week evolution of multiple sclerosis lesions with centripetal enhancement pattern on magnetic resonance imagi...

Mar 10th, 2023 - The objective of this study is to examine the risk factors and natural course of JCV infection and progressive multifocal leukoencephalopathy (PML). PML is a devastating, demyelinating neurological disease affecting the brain of patients with a co...

Mar 10th, 2023 - Cognitive impairment is common in and devastating to people with MS. MS is a common, chronic, central nervous system (CNS) disease characterized by inflammation, demyelination, and neurodegeneration. One of the most devastating symptoms of this di...

Mar 10th, 2023 - Centra nervous system (CNF) damage in multiple sclerosis (MS), are mainly attributed to myelin destruction, axonal abnormalities and subsequent degeneration, and are responsible for serious deficiencies. Current therapies are focused on the treatm...

Mar 16th, 2023 - Physicians should incorporate respiratory health care in early treatment plans for patients with neuromuscular diseases (NMD), according to new clinical guidelines from the American College of Chest Physicians (CHEST). Non-invasive ventilation, su...

Mar 15th, 2023 - Fertility treatment was not associated with an increased risk of relapse in women with multiple sclerosis (MS) or clinically isolated syndrome (CIS), retrospective data showed. Across 80 cycles, the mean annualized relapse rate (ARR) 12 months bef...

Mar 8th, 2023 - SAN DIEGO – Clinical characteristics and treatment responses in multiple sclerosis (MS) show unimodal distributions, which suggests that it is a homogeneous condition with lots of variation, rather than a mixture of conditions with different genet.

Mar 6th, 2023 - A blind comparison between a portable, ultra low-field magnetic resonance imaging (MRI) device and a traditional high-field MRI showed that the portable device performed well in detecting periventricular lesions in pateints with multiple sclerosis.

Mar 2nd, 2023 - A digital tool to measure walking has the potential to improve measurement of disability among patients with multiple sclerosis (MS). “When you measure disability, what you really want to know is how things are changing in the patient’s life and n.